Dr. John Cush RheumNow
5 years 6 months ago
Thanks to everyone who attended RheumNow Live 2021 in person and virtually! WE hope you enjoyed and learned from it. #RNL2021
While rheumatoid arthritis (RA) is not known to affect the liver directly, underlying liver disease and treatment-related effects on the liver can often become an obstacle in the management of many RA patients. In his Sunday presentation at RNL2021, Dr. Stanley Cohen detailed many issues liver disease that arise in the course of RA management and ways to overcome them.
Dr. John Cush RheumNow
5 years 6 months ago
Early RA pts given steroids (GC) do Not have short or long term benefits from GCs. 180 ERA pts given compared to 294 who did not. 5 yr F/U showed no differences in DAS28-CRP, HAQ or pain between groups. Steroids were used more in seronegative RA. https://t.co/CDUKDgsLRa
Dr. John Cush RheumNow
5 years 6 months ago
Using both glucocorticoids & PPI leads to additive risk of osteoporotic fractures - UK database studiedd 12351 RA pts - 1411 w/ OP Fx. Concomitant GCs + PPIs assoc w/ 1.6-fold risk of OP Fx (adj HR: 1.60) vs nonuse; more than 1.2-fold risk w/ either alone https://t.co/vvA6P5LEgs
Dr. John Cush RheumNow
5 years 6 months ago
We just started our last faculty panel on RA with audience Q&A.
#RNL2021 https://t.co/o1s2asdLcS
Dr. John Cush RheumNow
5 years 6 months ago
Mavrilimumab (anti-GM-CSF) metanalysis shows gret benefit in #RA - 1145 pts, 3 trials shows significant 12 week responses by: 1) DAS28-CRP remission (RR = 3.31); 2) ACR20 (RR = 2.38); 3) ACR50 (RR = 2.93) & 4) ACR70 (RR = 4.9). Where is it? https://t.co/9L5PFEB1DI
Dr. John Cush RheumNow
5 years 6 months ago
Spondyloarthritis faculty panel with audience Q&A #RNL2021 https://t.co/iSosAtHLCZ
Dr. John Cush RheumNow
5 years 6 months ago
Follow the hashtag #RNL2021 for all RheumNow Live coverage today!
Dr. John Cush RheumNow
5 years 6 months ago
Dr. Artie Kavanaugh leading the spondyloarthritis pod focusing on enthesitis and dactylitis management. #RNL2021 https://t.co/NCUwabTXVd
Nigil Haroon MD, PhD 💎🦜🌎🩺🔬 NigilHaroon
5 years 6 months ago
Join me at the @RheumNow SpA session happening now! #rheumatology #spondyloarthritis #ankylosing https://t.co/CTLq0xWQys
Dr. John Cush RheumNow
5 years 6 months ago
Leading the Rheumatoid Arthritis pod with discussions on pneumonia and RA and interstitial lung disease in RA. #RNL2021 https://t.co/psxMTHsOva
Dr. John Cush RheumNow
5 years 6 months ago
New podcast available! Dr. Jack Cush rants on the journal reports, news and FDA actions featured this past week on RheumNow.
https://t.co/rPnLp2NfRq https://t.co/TSTP2tWxXy
Dr. John Cush RheumNow
5 years 6 months ago
Our in-person participants engaging with the psoriatic panel #RNL2021 https://t.co/N0Cdos3Rhb
Dr. John Cush RheumNow
5 years 6 months ago
News Feature: Potent Topical Corticosteroids and the Risk of Osteoporotic Fractures
https://t.co/KazNPRXKNx https://t.co/pykBdbexzF
Olga Petryna DrPetryna
5 years 6 months ago
@RheumNow #RNL2021 Dr. Buttgereit on steroids in RA:
2.5 mg/d of prednisone increase total steroid amount in the body by 100% - great therapeutic effect but comes w/plethora of side effects.
Q: how do you feel out long term low dose steroids for RA?
